 | | RQJ | | Name: | deoxyproclavaminic acid | | Formula: | C8 H14 N2 O3 | | SMILES: | N1(C(C(=O)O)CCCN)C(=O)CC1 | | InChi: | InChI=1S/C8H14N2O3/c9-4-1-2-6(8(12)13)10-5-3-7(10)11/h6H,1-5,9H2,(H,12,13)/t6-/m0/s1 | | Synonyms: | (2S)-5-amino-2-(2-oxoazetidin-1-yl)pentanoic acid | | Definition date: | 2020-02-21 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | (2S)-5-amino-2-(2-oxoazetidin-1-yl)pentanoic acid |
|
 | | P4H | | Name: | [2,4-bis(oxidanyl)phenyl]-[3,4-bis(oxidanyl)phenyl]methanone | | Formula: | C13 H10 O5 | | SMILES: | Oc1ccc(c(O)c1)C(=O)c2ccc(O)c(O)c2 | | InChi: | InChI=1S/C13H10O5/c14-8-2-3-9(11(16)6-8)13(18)7-1-4-10(15)12(17)5-7/h1-6,14-17H | | Definition date: | 2020-04-15 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | [2,4-bis(oxidanyl)phenyl]-[3,4-bis(oxidanyl)phenyl]methanone |
|
 | | SK0 | | Name: | (1R)-6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol | | Formula: | C16 H16 Cl N O2 | | SMILES: | c31c(CCNCC1c2ccccc2)c(Cl)c(c(c3)O)O | | InChi: | InChI=1S/C16H16ClNO2/c17-15-11-6-7-18-9-13(10-4-2-1-3-5-10)12(11)8-14(19)16(15)20/h1-5,8,13,18-20H,6-7,9H2/t13-/m1/s1 | | Definition date: | 2020-08-24 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | (1R)-6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol |
|
 | | SK9 | | Name: | (1R)-6-chloro-3-methyl-1-(3-methylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol | | Formula: | C18 H20 Cl N O2 | | SMILES: | c2(cc3C(c1cccc(c1)C)CN(CCc3c(c2O)Cl)C)O | | InChi: | InChI=1S/C18H20ClNO2/c1-11-4-3-5-12(8-11)15-10-20(2)7-6-13-14(15)9-16(21)18(22)17(13)19/h3-5,8-9,15,21-22H,6-7,10H2,1-2H3/t15-/m1/s1 | | Definition date: | 2020-08-24 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | (1R)-6-chloro-3-methyl-1-(3-methylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol |
|
 | | EY6 | | Name: | 5-(2-fluoranylethoxy)-1H-indole | | Formula: | C10 H10 F N O | | SMILES: | FCCOc1ccc2[nH]ccc2c1 | | InChi: | InChI=1S/C10H10FNO/c11-4-6-13-9-1-2-10-8(7-9)3-5-12-10/h1-3,5,7,12H,4,6H2 | | Definition date: | 2020-02-18 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | 5-(2-fluoranylethoxy)-1~{H}-indole |
|
 | | EY9 | | Name: | 5-(2-methoxyethoxy)-1H-indole | | Formula: | C11 H13 N O2 | | SMILES: | COCCOc1ccc2[nH]ccc2c1 | | InChi: | InChI=1S/C11H13NO2/c1-13-6-7-14-10-2-3-11-9(8-10)4-5-12-11/h2-5,8,12H,6-7H2,1H3 | | Definition date: | 2020-02-18 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | 5-(2-methoxyethoxy)-1~{H}-indole |
|
 | | EYF | | Name: | 1-[(3-methoxyphenyl)methyl]-~{N}-oxidanyl-pyrrolo[2,3-b]pyridine-5-carboxamide | | Formula: | C16 H15 N3 O3 | | SMILES: | COc1cccc(Cn2ccc3cc(cnc23)C(=O)NO)c1 | | InChi: | InChI=1S/C16H15N3O3/c1-22-14-4-2-3-11(7-14)10-19-6-5-12-8-13(16(20)18-21)9-17-15(12)19/h2-9,21H,10H2,1H3,(H,18,20) | | Definition date: | 2020-02-19 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | 1-[(3-methoxyphenyl)methyl]-~{N}-oxidanyl-pyrrolo[2,3-b]pyridine-5-carboxamide |
|
 | | EYL | | Name: | ~{N}-oxidanyl-1-(phenylmethyl)pyrrolo[2,3-b]pyridine-4-carboxamide | | Formula: | C15 H13 N3 O2 | | SMILES: | ONC(=O)c1ccnc2n(Cc3ccccc3)ccc12 | | InChi: | InChI=1S/C15H13N3O2/c19-15(17-20)13-6-8-16-14-12(13)7-9-18(14)10-11-4-2-1-3-5-11/h1-9,20H,10H2,(H,17,19) | | Definition date: | 2020-02-19 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | ~{N}-oxidanyl-1-(phenylmethyl)pyrrolo[2,3-b]pyridine-4-carboxamide |
|
 | | EZU | | Name: | 1-cyclopentyl-6-[[(2R)-1-(2-oxa-6-azaspiro[3.3]heptan-6-yl)-1-oxidanylidene-propan-2-yl]amino]-5H-pyrazolo[3,4-d]pyrimidin-4-one | | Formula: | C18 H24 N6 O3 | | SMILES: | C[CH](NC1=Nc2n(ncc2C(=O)N1)C3CCCC3)C(=O)N4CC5(COC5)C4 | | InChi: | InChI=1S/C18H24N6O3/c1-11(16(26)23-7-18(8-23)9-27-10-18)20-17-21-14-13(15(25)22-17)6-19-24(14)12-4-2-3-5-12/h6,11-12H,2-5,7-10H2,1H3,(H2,20,21,22,25)/t11-/m1/s1 | | Definition date: | 2020-02-28 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | 1-cyclopentyl-6-[[(2~{R})-1-(2-oxa-6-azaspiro[3.3]heptan-6-yl)-1-oxidanylidene-propan-2-yl]amino]-5~{H}-pyrazolo[3,4-d]pyrimidin-4-one |
|
 | | U4V | | Name: | 3'-deoxy-3'-(4-{[(4-sulfamoylphenyl)amino]methyl}-1H-1,2,3-triazol-1-yl)thymidine | | Formula: | C19 H23 N7 O6 S | | SMILES: | c1(S(=O)(=O)N)ccc(cc1)NCc4nnn(C3CC(N2C=C(C(=O)NC2=O)C)OC3CO)c4 | | InChi: | InChI=1S/C19H23N7O6S/c1-11-8-25(19(29)22-18(11)28)17-6-15(16(10-27)32-17)26-9-13(23-24-26)7-21-12-2-4-14(5-3-12)33(20,30)31/h2-5,8-9,15-17,21,27H,6-7,10H2,1H3,(H2,20,30,31)(H,22,28,29)/t15-,16+,17+/m0/s1 | | Definition date: | 2020-04-21 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | 3'-deoxy-3'-(4-{[(4-sulfamoylphenyl)amino]methyl}-1H-1,2,3-triazol-1-yl)thymidine |
|
 | | V9S | | Name: | 6-[(8E)-8-{2-[4-(benzylcarbamoyl)-1,3-thiazol-2-yl]hydrazinylidene}-5,6,7,8-tetrahydronaphthalen-2-yl]-3-(2-phenylethoxy)pyridine-2-carboxylic acid | | Formula: | C35 H31 N5 O4 S | | SMILES: | s5c(N/N=C4/c3c(ccc(c1ccc(c(C(O)=O)n1)OCCc2ccccc2)c3)CCC4)nc(c5)C(NCc6ccccc6)=O | | InChi: | InChI=1S/C35H31N5O4S/c41-33(36-21-24-10-5-2-6-11-24)30-22-45-35(38-30)40-39-29-13-7-12-25-14-15-26(20-27(25)29)28-16-17-31(32(37-28)34(42)43)44-19-18-23-8-3-1-4-9-23/h1-6,8-11,14-17,20,22H,7,12-13,18-19,21H2,(H,36,41)(H,38,40)(H,42,43)/b39-29+ | | Definition date: | 2020-07-21 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | 6-[(8E)-8-{2-[4-(benzylcarbamoyl)-1,3-thiazol-2-yl]hydrazinylidene}-5,6,7,8-tetrahydronaphthalen-2-yl]-3-(2-phenylethoxy)pyridine-2-carboxylic acid |
|
 | | F05 | | Name: | 1H-isoindol-3-amine | | Formula: | C8 H8 N2 | | SMILES: | c1cccc2c1cnc2N | | InChi: | InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10) | | Definition date: | 2010-11-15 | | Last modified: | 2021-02-16 | | Identifier: | 2H-isoindol-1-amine |
|
 | | XYJ | | Name: | 3-[(1,3-dimethyl-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-yl)sulfanyl]-N-{[2-(morpholin-4-yl)ethyl]sulfonyl}propanamide | | Formula: | C16 H24 N6 O6 S2 | | SMILES: | C(NS(CCN1CCOCC1)(=O)=O)(CCSc3nc2c(C(N(C(N2C)=O)C)=O)n3)=O | | InChi: | InChI=1S/C16H24N6O6S2/c1-20-13-12(14(24)21(2)16(20)25)17-15(18-13)29-9-3-11(23)19-30(26,27)10-6-22-4-7-28-8-5-22/h3-10H2,1-2H3,(H,17,18)(H,19,23) | | Definition date: | 2021-01-20 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | 3-[(1,3-dimethyl-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-yl)sulfanyl]-N-{[2-(morpholin-4-yl)ethyl]sulfonyl}propanamide |
|
 | | XZS | | Name: | N-{5-[(2-{[3,5-difluoro-4-(1-methylpiperidin-4-yl)phenyl]amino}-5-methylpyrimidin-4-yl)amino]-2-fluorophenyl}-2-methylpropane-2-sulfonamide | | Formula: | C27 H33 F3 N6 O2 S | | SMILES: | c2c(cc(c(C1CCN(CC1)C)c2F)F)Nc3nc(c(C)cn3)Nc4ccc(F)c(NS(C(C)(C)C)(=O)=O)c4 | | InChi: | InChI=1S/C27H33F3N6O2S/c1-16-15-31-26(33-19-12-21(29)24(22(30)13-19)17-8-10-36(5)11-9-17)34-25(16)32-18-6-7-20(28)23(14-18)35-39(37,38)27(2,3)4/h6-7,12-15,17,35H,8-11H2,1-5H3,(H2,31,32,33,34) | | Definition date: | 2021-01-22 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | N-{5-[(2-{[3,5-difluoro-4-(1-methylpiperidin-4-yl)phenyl]amino}-5-methylpyrimidin-4-yl)amino]-2-fluorophenyl}-2-methylpropane-2-sulfonamide |
|
 | | XZV | | Name: | 4-(5-chlorofuran-2-carbonyl)-N-(cyclopropylmethyl)piperazine-1-carboxamide | | Formula: | C14 H18 Cl N3 O3 | | SMILES: | N2(CCN(C(c1ccc(Cl)o1)=O)CC2)C(NCC3CC3)=O | | InChi: | InChI=1S/C14H18ClN3O3/c15-12-4-3-11(21-12)13(19)17-5-7-18(8-6-17)14(20)16-9-10-1-2-10/h3-4,10H,1-2,5-9H2,(H,16,20) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | 4-(5-chlorofuran-2-carbonyl)-N-(cyclopropylmethyl)piperazine-1-carboxamide |
|
 | | XZY | | Name: | 4-(5-chlorofuran-2-carbonyl)-N-(2,2,2-trifluoroethyl)piperazine-1-carboxamide | | Formula: | C12 H13 Cl F3 N3 O3 | | SMILES: | N(CC(F)(F)F)C(N2CCN(C(=O)c1ccc(Cl)o1)CC2)=O | | InChi: | InChI=1S/C12H13ClF3N3O3/c13-9-2-1-8(22-9)10(20)18-3-5-19(6-4-18)11(21)17-7-12(14,15)16/h1-2H,3-7H2,(H,17,21) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | 4-(5-chlorofuran-2-carbonyl)-N-(2,2,2-trifluoroethyl)piperazine-1-carboxamide |
|
 | | Y0A | | Name: | N-butyl-4-(furan-2-carbonyl)piperazine-1-carboxamide | | Formula: | C14 H21 N3 O3 | | SMILES: | N2(CCN(C(=O)c1ccco1)CC2)C(NCCCC)=O | | InChi: | InChI=1S/C14H21N3O3/c1-2-3-6-15-14(19)17-9-7-16(8-10-17)13(18)12-5-4-11-20-12/h4-5,11H,2-3,6-10H2,1H3,(H,15,19) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | N-butyl-4-(furan-2-carbonyl)piperazine-1-carboxamide |
|
 | | Y0D | | Name: | N-(cyclopropylmethyl)-4-(thiophene-2-carbonyl)piperazine-1-carboxamide | | Formula: | C14 H19 N3 O2 S | | SMILES: | N(CC1CC1)C(N3CCN(C(=O)c2cccs2)CC3)=O | | InChi: | InChI=1S/C14H19N3O2S/c18-13(12-2-1-9-20-12)16-5-7-17(8-6-16)14(19)15-10-11-3-4-11/h1-2,9,11H,3-8,10H2,(H,15,19) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | N-(cyclopropylmethyl)-4-(thiophene-2-carbonyl)piperazine-1-carboxamide |
|
 | | Y0G | | Name: | N-(2-fluoro-4-methoxyphenyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide | | Formula: | C17 H18 F N3 O4 | | SMILES: | N2(C(=O)Nc1ccc(OC)cc1F)CCN(CC2)C(c3occc3)=O | | InChi: | InChI=1S/C17H18FN3O4/c1-24-12-4-5-14(13(18)11-12)19-17(23)21-8-6-20(7-9-21)16(22)15-3-2-10-25-15/h2-5,10-11H,6-9H2,1H3,(H,19,23) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | N-(2-fluoro-4-methoxyphenyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide |
|
 | | Y0J | | Name: | N-(1,3-benzoxazol-2-yl)-4-(furan-2-carbonyl)piperazine-1-carboxamide | | Formula: | C17 H16 N4 O4 | | SMILES: | n2c1c(cccc1)oc2NC(N4CCN(C(=O)c3ccco3)CC4)=O | | InChi: | InChI=1S/C17H16N4O4/c22-15(14-6-3-11-24-14)20-7-9-21(10-8-20)17(23)19-16-18-12-4-1-2-5-13(12)25-16/h1-6,11H,7-10H2,(H,18,19,23) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | N-(1,3-benzoxazol-2-yl)-4-(furan-2-carbonyl)piperazine-1-carboxamide |
|
 | | Y0Y | | Name: | 4-(furan-2-carbonyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide | | Formula: | C17 H19 N3 O4 | | SMILES: | N2(CCN(C(=O)c1ccco1)CC2)C(Nc3ccc(OC)cc3)=O | | InChi: | InChI=1S/C17H19N3O4/c1-23-14-6-4-13(5-7-14)18-17(22)20-10-8-19(9-11-20)16(21)15-3-2-12-24-15/h2-7,12H,8-11H2,1H3,(H,18,22) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | 4-(furan-2-carbonyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide |
|
 | | Y1A | | Name: | 4-(furan-2-carbonyl)-N-(propan-2-yl)piperazine-1-carboxamide | | Formula: | C13 H19 N3 O3 | | SMILES: | N2(CCN(C(=O)c1ccco1)CC2)C(NC(C)C)=O | | InChi: | InChI=1S/C13H19N3O3/c1-10(2)14-13(18)16-7-5-15(6-8-16)12(17)11-4-3-9-19-11/h3-4,9-10H,5-8H2,1-2H3,(H,14,18) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | 4-(furan-2-carbonyl)-N-(propan-2-yl)piperazine-1-carboxamide |
|
 | | Y1D | | Name: | N-(2,4-difluorophenyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide | | Formula: | C16 H15 F2 N3 O3 | | SMILES: | N1(CCN(CC1)C(c2ccco2)=O)C(Nc3c(cc(cc3)F)F)=O | | InChi: | InChI=1S/C16H15F2N3O3/c17-11-3-4-13(12(18)10-11)19-16(23)21-7-5-20(6-8-21)15(22)14-2-1-9-24-14/h1-4,9-10H,5-8H2,(H,19,23) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | N-(2,4-difluorophenyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide |
|
 | | Y1J | | Name: | N-(cyclopropylmethyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide | | Formula: | C14 H19 N3 O3 | | SMILES: | N2(CCN(C(=O)c1ccco1)CC2)C(NCC3CC3)=O | | InChi: | InChI=1S/C14H19N3O3/c18-13(12-2-1-9-20-12)16-5-7-17(8-6-16)14(19)15-10-11-3-4-11/h1-2,9,11H,3-8,10H2,(H,15,19) | | Definition date: | 2021-01-26 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | N-(cyclopropylmethyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide |
|
 | | Y1M | | Name: | N-[(3,4-dihydro-2H-1lambda~4~-thiophen-5-yl)methyl]-4-(furan-2-carbonyl)piperazine-1-carboxamide | | Formula: | C15 H21 N3 O3 S | | SMILES: | N2(CCN(C(=O)c1ccco1)CC2)C(NCC=3CCCS=3)=O | | InChi: | InChI=1S/C15H21N3O3S/c19-14(13-4-1-9-21-13)17-5-7-18(8-6-17)15(20)16-11-12-3-2-10-22-12/h1,4,9,22H,2-3,5-8,10-11H2,(H,16,20) | | Definition date: | 2021-01-26 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | N-[(3,4-dihydro-2H-1lambda~4~-thiophen-5-yl)methyl]-4-(furan-2-carbonyl)piperazine-1-carboxamide |
|